An SLCO2B1 mRNA Isoform Acts as a Noncoding RNA to Drive Cancer Progression by Triggering Protein Biosynthesis.

Area of Science:

• Molecular Biology
• Cancer Research
• RNA Biology

Background:

• The 5' untranslated region (5' UTR) of eukaryotic mRNA regulates translation efficiency.
• Alternative transcription start sites (TSSs) generate diverse mRNA isoforms with distinct 5' UTRs.
• Understanding these isoforms is crucial in diseases like hepatocellular carcinoma (HCC).

Purpose of the Study:

• To comprehensively analyze 5' UTR structure and protein abundance of RNA transcripts with altered TSSs in HCC.
• To identify novel mRNA isoforms and their functional roles in HCC pathogenesis.

Main Methods:

• Analysis of 5' UTR sequence structure and protein abundance in HCC.
• Identification and characterization of mRNA isoforms using advanced sequencing techniques.
• In vivo studies using orthotopic tumor xenograft models.

Main Results:

• Discovered a novel SLCO2B1 mRNA isoform (SLCO2B1-isoN) highly expressed in HCC, associated with poor prognosis.
• SLCO2B1-isoN possesses a stem-loop structure in its 5' end, abrogating translation and rendering it noncoding.
• This noncoding isoform stabilizes FMR1, promoting HCC progression via de novo protein synthesis.
• Targeting SLCO2B1-isoN significantly inhibited tumor growth and metastasis in vivo.

Conclusions:

• Revealed a functionally noncoding isoform of SLCO2B1 mRNA (SLCO2B1-isoN) in HCC.
• Demonstrated that SLCO2B1-isoN promotes HCC progression by stabilizing FMR1 and enhancing protein biosynthesis.
• Highlighted the dual coding and noncoding potential of mRNA isoforms and their therapeutic implications.